Rankings
▼
Calendar
PLSE FY 2025 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
FY 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$350,000
Gross Profit
-$1M
-360.0% margin
Operating Income
-$77M
-21982.6% margin
Net Income
-$73M
-20794.6% margin
EPS (Diluted)
$-1.08
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$54M
Stock-Based Comp.
$21M
Balance Sheet
Total Assets
$96M
Total Liabilities
$15M
Stockholders' Equity
$81M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$350,000
$0
—
Gross Profit
-$1M
$0
—
Operating Income
-$77M
-$56M
-36.8%
Net Income
-$73M
-$54M
-35.8%
← Q4 2024
All Quarters
Q1 2025 →